This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Dutch court upholds Astellas modified patent used in cancer treatment

( January 31, 2025, 14:23 GMT | Official Statement) -- MLex Summary: The District Court of The Hague has upheld the validity of Astellas Pharma's modified patent in a dispute with Synthon BV. The Dutch medicine producer had challenged the Japanese company's EP 3,725,778 B1, relating to cancer treatment medicine. Synthon sought to invalidate the patent, arguing it lacked inventiveness, but the court disagreed and ordered Synthon to pay 150,000 euros in legal costs.The decision, in Dutch, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections